Header Logo

Connection

RU CHEN to Humans

Back to Details
This is a "connection" page, showing publications RU CHEN has written about Humans.
RU CHEN
Connection Strength
0.287
Humans
  1. Metaproteomic analysis of human gut microbiome in digestive and metabolic diseases. Adv Clin Chem. 2020; 97:1-12.
    View in: PubMed
    Score: 0.018
  2. Proteome alterations in pancreatic ductal adenocarcinoma. Cancer Lett. 2020 01 28; 469:429-436.
    View in: PubMed
    Score: 0.017
  3. Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer. Sci Rep. 2017 08 11; 7(1):7950.
    View in: PubMed
    Score: 0.015
  4. Glycoproteins and glycoproteomics in pancreatic cancer. World J Gastroenterol. 2016 Nov 14; 22(42):9288-9299.
    View in: PubMed
    Score: 0.014
  5. Biomarkers for colitis-associated colorectal cancer. World J Gastroenterol. 2016 Sep 21; 22(35):7882-91.
    View in: PubMed
    Score: 0.014
  6. Proteomics analysis of bodily fluids in pancreatic cancer. Proteomics. 2015 Aug; 15(15):2705-15.
    View in: PubMed
    Score: 0.013
  7. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer. World J Gastroenterol. 2014 Dec 07; 20(45):17037-48.
    View in: PubMed
    Score: 0.012
  8. Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma. Lab Invest. 2015 Jan; 95(1):43-55.
    View in: PubMed
    Score: 0.012
  9. Tissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challenges. Proteomics. 2013 Feb; 13(3-4):710-21.
    View in: PubMed
    Score: 0.011
  10. Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma. Cancer Biol Ther. 2012 Aug; 13(10):899-907.
    View in: PubMed
    Score: 0.010
  11. Arousal of cancer-associated stroma: overexpression of palladin activates fibroblasts to promote tumor invasion. PLoS One. 2012; 7(1):e30219.
    View in: PubMed
    Score: 0.010
  12. Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics. J Proteome Res. 2011 Jan 07; 10(1):200-9.
    View in: PubMed
    Score: 0.009
  13. Pilot study of blood biomarker candidates for detection of pancreatic cancer. Pancreas. 2010 Oct; 39(7):981-8.
    View in: PubMed
    Score: 0.009
  14. Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia. Mol Cancer. 2010 Jun 15; 9:149.
    View in: PubMed
    Score: 0.009
  15. Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Mol Cell Proteomics. 2007 Aug; 6(8):1331-42.
    View in: PubMed
    Score: 0.007
  16. Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis. Pancreas. 2007 Jan; 34(1):70-9.
    View in: PubMed
    Score: 0.007
  17. Quantitative proteomic profiling of pancreatic cancer juice. Proteomics. 2006 Jul; 6(13):3871-9.
    View in: PubMed
    Score: 0.007
  18. Characterization of genomic instability in ulcerative colitis neoplasia leads to discovery of putative tumor suppressor regions. Cancer Genet Cytogenet. 2005 Oct 15; 162(2):99-106.
    View in: PubMed
    Score: 0.006
  19. Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape. Gastroenterology. 2005 Oct; 129(4):1187-97.
    View in: PubMed
    Score: 0.006
  20. The initiation of colon cancer in a chronic inflammatory setting. Carcinogenesis. 2005 Sep; 26(9):1513-9.
    View in: PubMed
    Score: 0.006
  21. Proteomic profiling of pancreatic cancer for biomarker discovery. Mol Cell Proteomics. 2005 Apr; 4(4):523-33.
    View in: PubMed
    Score: 0.006
  22. DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free. Am J Pathol. 2003 Feb; 162(2):665-72.
    View in: PubMed
    Score: 0.005
  23. Proteomic Investigation of Glyceraldehyde-Derived Intracellular AGEs and Their Potential Influence on Pancreatic Ductal Cells. Cells. 2021 04 24; 10(5).
    View in: PubMed
    Score: 0.005
  24. X-aptamers targeting Thy-1 membrane glycoprotein in pancreatic ductal adenocarcinoma. Biochimie. 2021 Feb; 181:25-33.
    View in: PubMed
    Score: 0.005
  25. Metaproteomics Study of the Gut Microbiome. Methods Mol Biol. 2019; 1871:123-132.
    View in: PubMed
    Score: 0.004
  26. Similarities and Differences of Blood N-Glycoproteins in Five Solid Carcinomas at Localized Clinical Stage Analyzed by SWATH-MS. Cell Rep. 2018 05 29; 23(9):2819-2831.e5.
    View in: PubMed
    Score: 0.004
  27. Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer. Proteomics Clin Appl. 2017 09; 11(9-10).
    View in: PubMed
    Score: 0.004
  28. Quantitative Proteomics Based on Optimized Data-Independent Acquisition in Plasma Analysis. J Proteome Res. 2017 02 03; 16(2):665-676.
    View in: PubMed
    Score: 0.004
  29. BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis. Gut. 2017 05; 66(5):852-862.
    View in: PubMed
    Score: 0.003
  30. Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions. Radiology. 2015 Dec; 277(3):644-61.
    View in: PubMed
    Score: 0.003
  31. Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma. J Proteome Res. 2014 Mar 07; 13(3):1293-306.
    View in: PubMed
    Score: 0.003
  32. Unexpected gain of function for the scaffolding protein plectin due to mislocalization in pancreatic cancer. Proc Natl Acad Sci U S A. 2013 Nov 26; 110(48):19414-9.
    View in: PubMed
    Score: 0.003
  33. Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1. Gastroenterology. 2013 Oct; 145(4):885-894.e3.
    View in: PubMed
    Score: 0.003
  34. Large-scale quantitative glycoproteomics analysis of site-specific glycosylation occupancy. Mol Biosyst. 2012 Nov; 8(11):2850-6.
    View in: PubMed
    Score: 0.003
  35. Pan-colonic field defects are detected by CGH in the colons of UC patients with dysplasia/cancer. Cancer Lett. 2012 Jul 28; 320(2):180-8.
    View in: PubMed
    Score: 0.003
  36. Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study. J Proteome Res. 2012 Mar 02; 11(3):1937-48.
    View in: PubMed
    Score: 0.003
  37. Proteomics portrait of archival lesions of chronic pancreatitis. PLoS One. 2011; 6(11):e27574.
    View in: PubMed
    Score: 0.002
  38. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. J Proteome Res. 2011 May 06; 10(5):2359-76.
    View in: PubMed
    Score: 0.002
  39. Mass spectrometry based glycoproteomics--from a proteomics perspective. Mol Cell Proteomics. 2011 Jan; 10(1):R110.003251.
    View in: PubMed
    Score: 0.002
  40. Quantitative proteomics investigation of pancreatic intraepithelial neoplasia. Electrophoresis. 2009 Apr; 30(7):1132-44.
    View in: PubMed
    Score: 0.002
  41. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med. 2006 Dec; 3(12):e516.
    View in: PubMed
    Score: 0.002
  42. Induction of microsatellite instability by oxidative DNA damage. Proc Natl Acad Sci U S A. 1998 Oct 13; 95(21):12468-73.
    View in: PubMed
    Score: 0.001
  43. An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants. Hum Genet. 1997 Dec; 101(2):121-5.
    View in: PubMed
    Score: 0.001
  44. Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res. 1995 Oct 01; 55(19):4264-7.
    View in: PubMed
    Score: 0.001
  45. Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis. J Med Genet. 1995 May; 32(5):330-5.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.